COR vs CAH stock comparison
Cencora vs. Cardinal Health · data as of November 13, 2026
Cencora (COR) has a market value of about $68.5B, Cardinal Health (CAH) about $65.0B. Over their latest twelve months Cencora had revenue of $337.4B and Cardinal Health $257.8B.
On our five checks Cardinal Health scores higher: 3.4 out of 5 (good) against 3.2 (average).
By area, the stronger company is Cardinal Health on future growth; Cencora on track record; Cardinal Health on financial health.
Cencora is cheaper on earnings (P/E 20.1 vs. 36.4).
Cencora leads on 11 of the compared lines and Cardinal Health on 10.
Side by side
| COR | CAH | |
|---|---|---|
| Size and price | ||
| Market cap | $68.5B | $65.0B |
| Share price | $359.03 | $281.10 |
| Score | ||
| Overall score (of 5) | 3.2 | 3.4 |
| Value | 3 | 3 |
| Future growth | 2 | 3 |
| Track record | 4 | 3 |
| Financial health | 2 | 3 |
| Shareholder returns | 5 | 5 |
| Valuation | ||
| P/E (TTM) | 20.1 | 36.4 |
| Forward P/E | 17.4 | 20.5 |
| Price / free cash flow | 17.7 | 13.3 |
| Price / sales | 0.2 | 0.3 |
| EV / EBITDA | 13.5 | 18.7 |
| PEG | — | 1.28 |
| DCF value vs. price | −14% | +16% |
| Business | ||
| Revenue | $337.4B | $257.8B |
| Net income | $3.5B | $1.8B |
| Free cash flow | $3.9B | $4.9B |
| Net margin | 1.0% | 0.7% |
| Gross margin (5-yr avg.) | 3.4% | 3.5% |
| ROIC (5-yr avg.) | 24.1% | 21.8% |
| Growth | ||
| Revenue growth (1 yr) | 9.3% | 14.2% |
| Revenue growth (5 yrs, per year) | 11.1% | 9.4% |
| EPS growth (5 yrs, per year) | — | 28.3% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$8.9B | -$3.6B |
| Dividend yield | 0.74% | 0.73% |
| Shareholder yield | 1.4% | 2.8% |
| Analysts | ||
| Upside to average target | +7% | +5% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: COR TTM to September 30, 2026, CAH TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Cencora or Cardinal Health?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Cardinal Health scores 3.4 out of 5 and Cencora 3.2; the table shows where each one is stronger.
Is Cencora cheaper than Cardinal Health?
On trailing earnings, Cencora trades at a P/E of 20.1 and Cardinal Health at 36.4, so Cencora is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Cencora or Cardinal Health?
Over five years Cencora grew revenue about 11.1% a year and Cardinal Health about 9.4% a year.
Which pays a higher dividend?
Cencora yields 0.74% and Cardinal Health 0.73%.
Full Cencora analysis → Full Cardinal Health analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.